Multilineage embryonic hematopoiesis requires hypoxic ARNT activity

  1. David M. Adelman,
  2. Emin Maltepe, and
  3. M. Celeste Simon
  1. Department of Pathology, Committee on Cancer Biology, Departments of Medicine and Molecular Genetics and Cell Biology, and the Howard Hughes Medical Institute (HHMI), University of Chicago, Chicago, Illinois 60637 USA

Abstract

Although most cells undergo growth arrest during hypoxia, endothelial cells and placental cytotrophoblasts proliferate in response to low O2. We demonstrate that proliferation of embryonic multilineage hematopoietic progenitors is also regulated by a hypoxia-mediated signaling pathway. This pathway requires HIF-1 (HIF-1α/ARNT heterodimers) because Arnt−/− embryoid bodies fail to exhibit hypoxia-mediated progenitor proliferation. Furthermore, Arnt−/− embryos exhibit decreased numbers of yolk sac hematopoietic progenitors. This defect is cell extrinsic, is accompanied by a decrease in ARNT-dependent VEGF expression, and is rescued by exogenous VEGF. Therefore, “physiologic hypoxia” encountered by embryos is essential for the proliferation or survival of hematopoietic precursors during development.

Keywords

Footnotes

  • Corresponding author.

  • Present address: Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 USA.

  • E-MAIL csimon{at}medicine.bsd.uchicago.edu; FAX (215) 746-5511.

    • Received July 9, 1999.
    • Accepted August 17, 1999.
| Table of Contents

Life Science Alliance